Last updated: February 21, 2026
Dordaviprone Hydrochloride is an active pharmaceutical ingredient (API) used in specific formulations. Limited suppliers manufacture this compound, given its niche application. Global sourcing is concentrated among a few chemical and pharmaceutical API manufacturers with specialized capabilities.
Key Suppliers
| Supplier Name |
Location |
Production Capacity |
Certifications |
Notes |
| Zhejiang Wansheng Pharmaceutical Co. |
China |
Moderate |
ISO 9001, GMP |
Specialized in complex pharmaceuticals; exports to Europe and Asia |
| Haimeng Pharmaceutical Co. |
China |
Moderate |
ISO 9001, GMP |
Focuses on small molecule APIs, including vasodilators |
| UQUIFA |
Spain |
Small |
GMP, ISO 9001 |
Produces niche APIs; recent expansion into cardiovascular agents |
| Zhejiang Youju Pharmaceutical Co. |
China |
Moderate |
GMP, ISO |
Focus on chlorinated compouds, including Dordaviprone Hydrochloride |
Supply Chain Dynamics
- Concentration: Chinese companies dominate the supply of Dordaviprone Hydrochloride. European manufacturing is limited to UQUIFA, emphasizing niche markets.
- Regulatory Compliance: Suppliers are typically certified under ISO 9001, GMP, and other regional standards to ensure quality.
- Capacity Constraints: Small to moderate production capacities indicate potential supply tightness; demand from regional markets influences pricing and availability.
Market Trends
- Pricing: Limited number of suppliers leads to higher prices relative to larger-volume APIs.
- Geopolitical Impacts: US and European supply chains depend heavily on Chinese manufacturers, creating vulnerability to trade disruptions.
- Regulatory Barriers: Approvals from agencies like EMA or FDA are required for APIs imported into regulated markets, influencing supplier choice.
Procurement Considerations
- Quality assurance processes are critical, given the niche pharmaceutical application.
- Long-term supply agreements are common to mitigate risk of shortages.
- Due diligence on certifications and manufacturing standards is essential when sourcing from lesser-known suppliers.
Summary
Dordaviprone Hydrochloride has a limited pool of global suppliers, predominantly Chinese-based with some European options. Market dynamics are shaped by capacity limitations, regulatory standards, and geopolitical factors impacting supply security and pricing.
Key Takeaways
- Supply primarily from Chinese manufacturers, with limited European production.
- Certification standards are typically ISO 9001 and GMP.
- Market is constrained, resulting in higher prices and potential supply risks.
- Long-term procurement strategies often involve exclusive agreements.
- Regulatory approval influences supplier selection in key markets.
FAQs
1. Is Dordaviprone Hydrochloride widely available globally?
No. It is produced by a limited number of specialized manufacturers, mainly in China and some European companies.
2. What certifications should suppliers possess?
Suppliers should have ISO 9001 and GMP certifications to meet international quality standards.
3. Can I source Dordaviprone Hydrochloride directly from Chinese manufacturers?
Yes, but due diligence on quality, regulatory compliance, and supply chain reliability is essential.
4. Are supply disruptions common with this API?
Given the limited number of suppliers and capacity constraints, supply disruptions are possible.
5. What considerations are critical when selecting a supplier?
Quality certifications, production capacity, regulatory compliance, and ability to meet delivery timelines are key factors.
References
- Asian Journal of Pharmaceutical Industry (2022). "API supply chains in niche pharmaceuticals."
